Arthrosi Therapeutics has closed a $153 million Series E funding round. This late-stage biotechnology company is focused on developing a next-generation URAT1 inhibitor, which has the potential to be ...

Brigham and Women's nurses postponed the Oct. 14 strike to vote on a final offer. See the pay, insurance, and staffing terms, and what patients face. Parents Should Check Amazon Bath Seats and ...

Crystalys Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for gout, a condition characterized by high levels of uric acid in the blood that can ...

LAS VEGAS — In patients with gout, there is indirect evidence that serum urate levels lower than those currently recommended can reduce the risk for flares, which might be even further reduced when ...

DETROIT, MICHIGAN - October 7, 2026 (NEWMEDIAWIRE) - Blame it on an aging population, obesity, lifestyle choices or a combination of all the above, but either way, the number of cases of gout globally ...

Please provide your email address to receive an email when new articles are posted on . Participants briefed on biological causes were more likely to believe that long-term medication can improve gout ...

Dotinurad is a next-generation, once daily oral, URAT1 inhibitor with potential for best-in-class safety and efficacy, as supported by extensive clinical data from Japan, China and other Asian markets ...

Medically reviewed byJimmy Almond, M.D. Once known as “the disease of kings” due to its association with overindulgence in rich foods and alcohol, gout is a form of arthritis characterized by sudden, ...

INDIANAPOLIS (WISH) — Gout is described as the most painful arthritic condition, and yet it's nicknamed the "disease of kings." That's because it was historically understood as only caused by diet and ...